WOMAC

Biomarker

2 papers

  • Human trial1
  • Humans1

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 2Aug 2026: 1Sep 2026: 3Oct 2026: 18 in 12 months
The New England Journal of Medicine

Retatrutide reduces weight and pain in adults with obesity

Mean body weight fell up to 25.0% with retatrutide versus 3.9% on placebo over 80 weeks in adults with obesity.Mean body weight fell up to 25.0% with retatrutide versus 3.9% on placebo over 80 weeks in adults with obesity.

Randomised trial in 2,339 peopleRetatrutide